title: Blood safety implications of donors using HIV pre-exposure prophylaxis.
abstract: HIV pre-exposure prophylaxis (PrEP) is the use of one or more antiretroviral medications (in combination) to prevent HIV infection. The most commonly used PrEP medication (Truvada®, Gilead Sciences, Inc.) acts by inhibiting HIV-1 reverse transcriptase. If someone who is using PrEP unknowingly becomes HIV infected (termed 'PrEP breakthrough infection'), there may be suppressed viral replication resulting in a virus level undetectable by the most sensitive HIV NAT. Failure to seroconvert and seroreversion (loss of previously detectable HIV antibodies) have also both been observed with 2nd, 3rd and 4th generation screening immunoassays, as well as Western blot assays. If such a person was tested in the course of donating blood, the results may therefore be difficult to interpret. The index of suspicion for possible PrEP 'interference' should be highest in the context of concomitant low-level positive or 'greyzone' reactivity on HIV NAT and serological tests, which is an unusual pattern in acutely HIV-infected blood donors. Another possibility is detectable HIV RNA with negative HIV serology (i.e. a potential 'NAT yield' case) but without subsequent HIV seroconversion (or disappearance of HIV RNA). Excluding antiretroviral therapy or PrEP use by the donor in such circumstances would be important. The current rarity of PrEP breakthrough infection indicates that any potential safety risk is likely very small. However, considering the increasing use of PrEP we feel it is prudent for those interpreting HIV donor screening test results to consider the potential for PrEP interference.
authors.affiliation: Australian Red Cross Blood Service, Perth, WA, Australia.
authors.forename: C R
authors.identifier: http://orcid.org/0000-0002-0234-4507
authors.initials: CR
authors.lastname: Seed
authors.affiliation: Australian Red Cross Blood Service, Sydney, NSW, Australia.
authors.forename: H
authors.initials: H
authors.lastname: Yang
authors.affiliation: Australian Red Cross Blood Service, Perth, WA, Australia.
authors.forename: J F
authors.initials: JF
authors.lastname: Lee
mesh_terms: D001782:Blood Donors; D058731:Blood Safety; D015483:HIV Antibodies / Q000097:blood; D015658:HIV Infections / Q000097:blood / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D065129:Pre-Exposure Prophylaxis; D012698:Serologic Tests
chemical_list: D015483:HIV Antibodies
keywords: blood donation testing; blood safety; transfusion-transmissible infections